PA
CELG

Perennial Advisors’s Celgene Corp CELG Stock Holding History

Perennial Advisors’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-235
Closed -$15K – 213
2018
Q4 		$15K Hold
235
– – 0.01% 149
2018
Q3 		$21K Hold
235
– – 0.01% 143
2018
Q2 		$19K Hold
235
– – 0.01% 145
2018
Q1 		$21K Hold
235
– – 0.01% 136
2017
Q4 		$25K Hold
235
– – 0.02% 135
2017
Q3 		$34K Hold
235
– – 0.02% 112
2017
Q2 		$31K Hold
235
– – 0.02% 110
2017
Q1 		$29K Hold
235
– – 0.02% 109
2016
Q4 		$27K Buy
+235
New +$26.2K 0.02% 112

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Perennial Advisors's CELG Position: Q1 2019 in Review

Perennial Advisors sold out of Celgene Corp (CELG) in Q1 2019, closing a stake of 235 shares — an estimated $15K sold.

Perennial Advisors first reported a position in CELG in Q4 2016 and held it in 9 quarters. The position peaked at $34K in Q3 2017. 1,389 funds tracked by Wall St. Rank hold CELG as of Q1 2019.

  • Perennial Advisors reported no remaining Celgene Corp position as of Q1 2019 after selling out during the quarter.
  • Perennial Advisors sold 235 Celgene Corp shares in Q1 2019, an estimated $15K.
  • Perennial Advisors first reported a position in Celgene Corp in Q4 2016 and held it in 9 quarters.
  • Perennial Advisors's Celgene Corp position peaked at $34K in Q3 2017.
  • 1,389 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2019.

Based on Perennial Advisors's 13F filing for Q1 2019, filed 30 Apr 2019.